arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Alector, Inc.

ALEC
$2.02 ▲ +0.02 (+0.75%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
36 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Neutral
auto_awesome

Analytical Summary

Alector, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $224.7M
Dividend Yield
Revenue Growth -57.8%
Op. Margin None
ROIC 246.1%
FCF / Share $-0.31
Trailing P/E
Price / Book
FCF Yield
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Sep 23, 2026.

36-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.32M
↓ -57.8%
Net Income Profit after all expenses
$-22.93M
↑ +43.3%
Operating Margin Operating profit as % of sales
-433.6%
↓ -3144.0%
FCF / Share Free cash flow per share
$-0.31
↑ +31.8%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%

Health Breakdown

Financial Health
35
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 36 quarters